Drug Shortage Report for JAMP-NYSTATIN ORAL SUSPENSION USP
| Report ID | 211795 |
| Drug Identification Number | 02433443 |
| Brand name | JAMP-NYSTATIN ORAL SUSPENSION USP |
| Common or Proper name | Nystatin Oral Suspension USP |
| Company Name | JAMP PHARMA CORPORATION |
| Market Status | MARKETED |
| Active Ingredient(s) | NYSTATIN |
| Strength(s) | 100000UNIT |
| Dosage form(s) | SUSPENSION |
| Route of administration | ORAL ORAL |
| Packaging size | 100 |
| ATC code | A07AA |
| ATC description | INTESTINALANTIINFECTIVES |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | |
| Actual start date | 2023-11-27 |
| Estimated end date | 2025-05-31 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2025-01-23 |
| Company comments | Under allocation |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1310 RUE NOBEL BOUCHERVILLE, QUEBEC CANADA J4B 5H3 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2023-11-28 | French | Compare |
| v1 | 2023-11-28 | English | Compare |